Which is the best protocol and cut-off point in the 4-metre gait speed test to discriminate exercise capacity in COPD? / Qual o melhor protocolo e ponto de corte no teste 4-metre gait speed para discriminar capacidade de exercício na Doença Pulmonar Obstrutiva Crônica?

Objective To determine the discriminative capacity and cut-off point of different 4-metre gait speed test (4MGS) protocols in identifying preserved or reduced exercise capacity using the six-minute walk test (6MWT) in patients with Chronic Obstructive Pulmonary Disease (COPD); also, to compare 4MGS protocols and characteristics of individuals according to the best cut-off point. Methods We evaluated fifty-six patients with COPD, all of which were submitted to the assessment of anthropometric characteristics, pulmonary function (spirometry) and functional exercise capacity (6MWT and four protocols of the 4MGS). In the 4MGS test, patients were instructed to walk at normal pace and at maximum speed in a 4 meters course (4MGS 4m - usual pace and at maximum) and 8 meters course (4MGS 8m - usual pace and at maximum). Results Only the 4MGS 4m-maximum protocol was able to identify preserved exercise capacity in the 6MWT (AUC=0.70) with moderate correlation between them (r=0.52; P=0<0.0001). The cut-off point found in the 4MGS 4m-maximum was 1.27 m/s. Patients with preserved exercise capacity (4MGS 4m-maximum ≥1.27m/s) walker greater distances on the 6MWT in %pred (91±2 vs 76±3; P<0.0001). In the other comparisons involving gender, BMI, FEV1% pred and GOLD index there were no significant differences between the groups. In addition, the agreement of individuals classified as preserved and reduced exercise capacity in the 6MWT and 4MGS 4m-maximum was significant (P = 0.008). Conclusion The 4MGS 4m-maximum test can be used to discriminate preserved exercise capacity in patients with COPD and correlates with the 6MWT.

Profile and determinants of daily physical activity objectively assessed in university students.

BACKGROUND: The aim of this study was to quantify and compare physical activity (PA) levels of university students from different fields of study, and to investigate its correlates. METHODS: 221 students (111 female, 20 [18-23] years), from different study fields were cross-sectionally assessed for daily PA (pedometer), cardiorespiratory fitness (20 m Shuttle Run Test-20mSRT), health-related quality of life (HRQoL), anxiety and depression symptoms. RESULTS: In general, 60% of the students were physically active (>8000 steps/day), presented good HRQoL and cardiorespiratory fitness, minimal symptoms of depression and moderate of anxiety. The highest PA level was observed in students from physical education and sport sciences, and the lowest in those from social sciences (median [IQR]: 9882 [8435-13510] versus 7593 [6070-9753] steps/day, respectively; P<0.01). Male students were more active than female. Steps/day was moderately associated with VO2max (r=0.42), VO2%pred (r=0.41) and distance achieved in the 20mSRT (r=0.43) (P<0.0001 for all), and weakly associated with anxiety symptoms (r=-0.20; P=0.004) and HRQoL domains (0.15

Best Protocol for the Sit-to-Stand Test in Subjects With COPD.

BACKGROUND: Different protocols for the sit-to-stand test (STS) are available for assessing functional capacity in COPD. We sought to correlate each protocol of the STS (ie, the 5-repetition [5-rep STS], the 30-s STS, and the 1-min STS) with clinical outcomes in subjects with COPD. We also aimed to compare the 3 protocols of the STS, to verify their association and agreement, and to verify whether the 3 protocols are able to predict functional exercise capacity and physical activity in daily life (PADL). METHODS: 23 subjects with COPD (11 men; FEV1 53 ± 15% predicted) performed 3 protocols of the STS. Subjects also underwent the following assessments: incremental shuttle walking test, 6-min walk test (6MWT), 4-m gait speed test (4MGS), 1-repetition maximum of quadriceps muscle, assessment of PADL, and questionnaires on health-related quality of life and functional status. RESULTS: The 1-min STS showed significant correlations with the 6MWT (r = 0.40), 4MGS (r = 0.64), and PADL (0.40 ≤ r ≤ 0.52), and the 5-rep STS and 30-s STS were associated with the 4MGS (r = 0.54 and r = 0.52, respectively). The speed differed for each protocol (5-rep STS 0.53 ± 0.16 rep/s, 30-s STS 0.48 ± 0.13 rep/s, 1-min STS 0.45 ± 0.11 rep/s, P = .01). However, they presented good agreement (intraclass correlation coefficient ≥ 0.73 for all) and correlated well with each other (r ≥ 0.68 for all). More marked changes in peripheral oxygen saturation (P = .004), heart rate (P < .001), blood pressure (P < .001), dyspnea (P < .001), and leg fatigue (P < .001) were found after the 1-min STS protocol. Furthermore, the 3 protocols were equally able to identify subjects with low exercise capacity or preserved exercise capacity. CONCLUSIONS: The 1-min STS generated higher hemodynamic demands and correlated better with clinical outcomes in subjects with COPD. Despite the difference in speed performance and physiological demands between the 5-rep STS and 1-min STS, there was a good level of agreement among the 3 protocols. In addition, all 3 tests were able to identify subjects with low exercise capacity or preserved exercise capacity.

Heart Rate Recovery, Physical Activity Level, and Functional Status in Subjects With COPD.

BACKGROUND: A normal heart rate reflects the balance between the sympathetic and parasympathetic autonomic nervous system. When the difference between heart rate at the end of an exercise test and after 1 min of recovery, known as the 1-min heart rate recovery, is ≤ 12 beats/min, this may indicate an abnormal delay. We sought to compare physical activity patterns and subjects' functional status with COPD with or without delayed 1-min heart rate recovery after the 6-min walk test (6MWT). METHODS: 145 subjects with COPD (78 men, median [interquartile range (IQR)] age 65 [60-73] y, body mass index 25 [21-30] kg/m2, FEV1 45 ± 15% predicted) were underwent the following assessments: spirometry, 6MWT, functional status, and physical activity in daily life (PADL). A delayed heart rate recovery of 1 min was defined as ≤ 12 beats/min. RESULTS: Subjects with delayed 1-min heart rate recovery walked a shorter distance in the 6MWT compared to subjects without delayed heart rate recovery (median [IQR] 435 [390-507] m vs 477 [425-515] m, P = .01; 81 [71-87] vs 87 [79-98]% predicted, P = .002). Regarding PADL, subjects with delayed heart rate recovery spent less time in the standing position (mean ± SD 185 ± 89 min vs 250 ± 107 min, P = .002) and more time in sedentary positions (472 ± 110 min vs 394 ± 129 min, P = .002). Scores based on the self-care domain of the London Chest Activity of Daily Living questionnaire and the activity domain of the Pulmonary Functional Status and Dyspnea questionnaire were also worse in the group with delayed heart rate recovery (6 ± 2 points vs 5 ± 2 points; P = .039 and 29 ± 24 points vs 19 ± 17 points; P = .037, respectively). CONCLUSIONS: Individuals with COPD who exhibit delayed 1-min heart rate recovery after the 6MWT exhibited worse exercise capacity as well as a more pronounced sedentary lifestyle and worse functional status than those without delayed heart rate recovery. Despite its assessment simplicity, heart rate recovery after the 6MWT can be further explored as a promising outcome in COPD.

4-Meter Gait Speed Test in Chronic Obstructive Pulmonary Disease: INTERRATER RELIABILITY USING A STOPWATCH.

PURPOSE: 4-meter gait speed (4MGS) is increasingly used to assess functional performance in patients with chronic obstructive pulmonary disease. However, the current literature lacks information regarding some technical standards for this test. Therefore, the purpose of this study was to compare and to evaluate the interrater reliability between a stopwatch and video recording used as timing systems for the 4MGS in patients with chronic obstructive pulmonary disease, as well as to verify the interrater reliability between 2 observers measuring the 4MGS time using a manual stopwatch. METHODS: Fifty-one patients performed the 4MGS using 4 different protocols (random order): walking at the usual and maximum speed in a 4-meter course and walking at the same 2 speeds on an 8-m course using a 2-m acceleration zone, a 4-meter timing area, and a 2-m deceleration zone. Gait speed was measured simultaneously using a stopwatch and a video recording. In a subanalysis (n = 24), 2 independent observers timed the 4MGS using a stopwatch. RESULTS: There was no significant difference in comparison between the 2 timing methods (P > .05 for all), and the reliability between video recording and stopwatch was excellent in all 4MGS studied protocols (intraclass correlation coefficient ≥ 0.91). Moreover, when comparing gait speed measured by 2 observers using a stopwatch, no significant difference was found among all proposed protocols (P > .05 for all), and there was also excellent reliability between the 2 independent observers (intraclass correlation coefficient ≥ 0.94). CONCLUSION: The stopwatch, a low-cost and feasible tool, is reliable as a timing device for the 4MGS in patients with chronic obstructive pulmonary disease.

Can the six-minute walk distance predict the occurrence of acute exacerbations of COPD in patients in Brazil? / A distância percorrida no teste de caminhada de seis minutos pode predizer a ocorrência de exacerbações agudas da DPOC em pacientes brasileiros?

ABSTRACT Objective: To evaluate whether a six-minute walk distance (6MWD) of < 80% of the predicted value can predict the occurrence of acute exacerbations of COPD in patients in Brazil over a 2-year period. Methods: This was a retrospective cross-sectional study involving 50 COPD patients in Brazil. At enrollment, anthropometric data were collected and patients were assessed for pulmonary function (by spirometry) and functional exercise capacity (by the 6MWD). The patients were subsequently divided into two groups: 6MWD ≤ 80% of predicted and 6MWD > 80% of predicted. The occurrence of acute exacerbations of COPD over 2 years was identified by analyzing medical records and contacting patients by telephone. Results: In the sample as a whole, there was moderate-to-severe airflow obstruction (mean FEV1 = 41 ± 12% of predicted) and the mean 6MWD was 469 ± 60 m (86 ± 10% of predicted). Over the 2-year follow-up period, 25 patients (50%) experienced acute exacerbations of COPD. The Kaplan-Meier method showed that the patients in whom the 6MWD was ≤ 80% of predicted were more likely to have exacerbations than were those in whom the 6MWD was > 80% of predicted (p = 0.01), whereas the Cox regression model showed that the former were 2.6 times as likely to have an exacerbation over a 2-year period as were the latter (p = 0.02). Conclusions: In Brazil, the 6MWD can predict acute exacerbations of COPD over a 2-year period. The risk of experiencing an acute exacerbation of COPD within 2 years is more than twice as high in patients in whom the 6MWD is ≤ 80% of predicted.

RESUMO Objetivo: Avaliar se a distância percorrida no teste de caminhada de seis minutos (DTC6) < 80% do valor previsto pode predizer a ocorrência de exacerbações agudas da DPOC ao longo de 2 anos em pacientes brasileiros. Métodos: Estudo transversal, retrospectivo, com 50 pacientes brasileiros com diagnóstico de DPOC. Após a admissão, os pacientes foram submetidos à coleta de dados antropométricos, avaliação da função pulmonar (resultados espirométricos) e da capacidade funcional de exercício (DTC6), sendo posteriormente divididos em dois grupos: DTC6 ≤ 80% do predito e DTC6 > 80% do predito. A ocorrência de exacerbações agudas da DPOC ao longo de 2 anos foi identificada por meio de registros de prontuários e contato telefônico. Resultados: A amostra geral apresentou obstrução moderada/grave ao fluxo aéreo (média de VEF1 = 41 ± 12% do predito) e média de DTC6 de 469 ± 60 m (86 ± 10% do predito). Nos 2 anos de seguimento após a realização do teste, 25 pacientes (50%) apresentaram exacerbação aguda da DPOC. O método de Kaplan-Meier mostrou que os pacientes com DTC6 ≤ 80% do predito apresentaram exacerbação mais frequentemente que pacientes com desempenho > 80% do predito (p = 0,01), enquanto o modelo de regressão de Cox mostrou que os pacientes no primeiro grupo apresentavam 2,6 mais chances de apresentar exacerbação em 2 anos em comparação ao segundo grupo (p = 0,02). Conclusões: A DTC6 é capaz de predizer exacerbações agudas da DPOC em pacientes brasileiros ao longo de 2 anos. Pacientes com DTC6 ≤ 80% do valor predito têm mais que o dobro de chances de apresentar exacerbação em 2 anos.

Peripheral muscle training in patients with chronic obstructive pulmonary disease: novel approaches and recent advances.

INTRODUCTION: Pulmonary rehabilitation is one of the most effective non-pharmacological management options for individuals with chronic obstructive pulmonary disease (COPD). Exercise training is the cornerstone of pulmonary rehabilitation, however considerable variability exists regarding the way it is delivered across the world. It is widely accepted that efforts should be made to tailor specific therapeutic approaches to individuals' needs. This applies as much to respiratory medicine as it does to respiratory rehabilitation. Areas covered: This narrative review examines the emerging literature evaluating advancements of exercise training modalities targeting peripheral muscle function in people with COPD. It aims to highlight practical considerations regarding the delivery key evidence regarding clinical effectiveness, as well as highlight some of the and evaluation of their effectiveness to inform clinical practice. Expert commentary: Although novel therapies may offer advantages over more 'traditional' training methods under specific circumstances, challenges regarding the potential impact upon clinical rehabilitation, the identification of the best candidates for such therapy and access to equipment may pose realistic barriers to their more widespread clinical implementation. Future directions regarding the ways in which these barriers could be overcome will be discussed, including identification of the key research priorities to optimize evidence-based practice in this area.

Can the six-minute walk distance predict the occurrence of acute exacerbations of COPD in patients in Brazil?

OBJECTIVE: To evaluate whether a six-minute walk distance (6MWD) of < 80% of the predicted value can predict the occurrence of acute exacerbations of COPD in patients in Brazil over a 2-year period. METHODS: This was a retrospective cross-sectional study involving 50 COPD patients in Brazil. At enrollment, anthropometric data were collected and patients were assessed for pulmonary function (by spirometry) and functional exercise capacity (by the 6MWD). The patients were subsequently divided into two groups: 6MWD ≤ 80% of predicted and 6MWD > 80% of predicted. The occurrence of acute exacerbations of COPD over 2 years was identified by analyzing medical records and contacting patients by telephone. RESULTS: In the sample as a whole, there was moderate-to-severe airflow obstruction (mean FEV1 = 41 ± 12% of predicted) and the mean 6MWD was 469 ± 60 m (86 ± 10% of predicted). Over the 2-year follow-up period, 25 patients (50%) experienced acute exacerbations of COPD. The Kaplan-Meier method showed that the patients in whom the 6MWD was ≤ 80% of predicted were more likely to have exacerbations than were those in whom the 6MWD was > 80% of predicted (p = 0.01), whereas the Cox regression model showed that the former were 2.6 times as likely to have an exacerbation over a 2-year period as were the latter (p = 0.02). CONCLUSIONS: In Brazil, the 6MWD can predict acute exacerbations of COPD over a 2-year period. The risk of experiencing an acute exacerbation of COPD within 2 years is more than twice as high in patients in whom the 6MWD is ≤ 80% of predicted.

Trinta minutos de repouso entre dois testes de caminhada de 6 minutos são suficientes para recuperação cardiovascular e sintomatológica em pacientes com doença pulmonar obstrutiva crônica? / ¿Son suficientes treinta minutos de descanso entre dos test de caminata de 6 minutos para recuperación cardiovascular y de síntomas en pacientes con enfermedad pulmonar obstructiva crónica? / Are thirty minutes of rest between two 6-Minute Walk Tests enough for cardiovascular and symptomatic recovery for patients with chronic obstructive pulmonary disease?

RESUMO Dois testes da caminhada de 6 minutos (TC6min) são necessários para avaliação da capacidade funcional de exercício em pacientes com doença pulmonar obstrutiva crônica (DPOC). Apesar de a American Thoracic Society (ATS) preconizar um intervalo de 1 hora entre dois testes, não se sabe se um período menor poderia ser utilizado para normalização das variáveis fisiológicas. O objetivo foi verificar se o intervalo de 30 minutos de repouso entre dois TC6min seria suficiente para que as variáveis cardiovasculares e sintomatológicas retornassem aos valores basais. Duzentos e quinze pacientes com DPOC (121H, 66±8 anos; VEF1: 44[32-57]% previsto) realizaram dois TC6min com intervalo de 30 minutos entre eles. Foram mensuradas antes e após os testes, pressão arterial (PA), frequência cardíaca (FC), saturação periférica de oxigênio (SpO2) e grau de dispneia e fadiga. Os pacientes caminharam maior distância no segundo teste (TC6min1: 450 [390-500]m vs TC6min2: 470 [403-515]m; p<0,0001). A FC inicial foi maior no segundo TC6min (FC inicial TC6min1: 83 [73-91]bpm vs TC6min2: 83 [75-93]bpm; p=0,001). Dispneia e fadiga foram menores antes do segundo teste (Borg dispneia inicial TC6min1: 0,5 [0-2] vs TC6min2: 0 [0-2]; p=0,0006 e Borg fadiga inicial TC6min1: 0 [0-2] vs TC6min2: 0 [0-2]; p=0,007). Não houve diferenças quanto à PA e SpO2 (p>0,05 para todos). Embora haja diferença estatisticamente significante na FC inicial entre o primeiro e segundo teste, tal achado não parece ser clinicamente relevante. Portanto, trinta minutos de repouso entre dois TC6min são suficientes para recuperação sintomatológica e cardiovascular em pacientes com DPOC.

RESUMEN Dos test de caminata de 6 minutos (TC6min) son necesarios para que se evalúe la capacidad funcional de ejercicio en pacientes con enfermedad pulmonar obstructiva crónica (EPOC). Aunque la American Thoracic Society (ATS) sugiere 1 hora de intervalo entre dos test, todavía se desconoce si puede utilizarse un periodo menor para normalización de las variables fisiológicas. En este estudio se comprobó que es suficiente el intervalo de 30 minutos de descanso entre dos TC6min para que las variables cardiovasculares y de síntomas vuelvan a sus valores de referencia. El estudio se llevó a cabo con 215 pacientes con EPOC (121H, 66±8 años; VEF1: 44[32-57]% previsto), que hicieron dos TC6min con intervalos de 30 minutos. Antes y después de los test se midieron la presión arterial (PA), la frecuencia cardíaca (FC), la saturación de oxígeno (SpO2) y el grado de disnea y de cansancio. Los pacientes caminaron una distancia más grande en el segundo test (TC6min1: 450 [390-500]m vs TC6min2: 470 [403-515]m; p<0,0001). La FC fue mayor en el segundo TC6min (FC inicial TC6min1: 83 [73-91]lpm vs TC6min2: 83 [75-93]lpm; p=0,001). La disnea y el cansancio fueron menores antes del segundo test (Borg disnea inicial TC6min1: 0,5 [0-2] vs TC6min2: 0 [0-2]; p=0,0006 y Borg cansancio inicial TC6min1: 0 [0-2] vs TC6min2: 0 [0-2]; p=0,007). En cuanto a la PA y la SpO 2 no hubo diferencias significativas con p>0,05 para todos. Aunque tenga diferencia estadística significante en la FC inicial entre el primer y el segundo test, el resultado no es clínicamente relevante, por lo tanto, los 30 minutos de descanso entre dos TC6min son suficientes para la recuperación cardiovascular y de síntomas en pacientes con EPOC.

ABSTRACT Two 6-Minute Walk Tests (6MWT) are required to evaluate functional capacity of exercise in patients with Chronic Obstructive Pulmonary Disease (COPD). Despite the fact that the American Thoracic Society (ATS) has proposed a one-hour interval between two tests, it is unknown whether a shorter period could be used for the normalization of physiological variables. We aimed to verify that an interval of 30 minutes of rest between two 6MWT is sufficient for cardiovascular and symptomatic variables to return to their basal levels. Two hundred and fifteen patients with COPD (121H, 66±8 years; FEV1: 44 [32-57]% predicted) performed two 6MWT with a thirty-minute interval between them. Before and after the tests, we measured Blood Pressure (BP), Heart Rate (HR), peripheral oxygen saturation (SpO2), degree of dyspnea, and fatigue. Patients walked the longest distance in the second test (6MWT1: 450 [390-500]m vs 6MWT2: 470 [403-515]m; p<0.0001). The initial HR was greater in the second 6MWT (initial HR 6MWT1: 83 [73-91]bpm vs 6MWT2: 83 [75-93]bpm; p=0.001). Dyspnea and fatigue were lower before the second test (initial Borg dyspnea 6MWT1: 0.5 [0-2]m vs 6MWT2: 0 [0-2]; p = 0.0006 and initial Borg fatigue 6MWT1: 0 [0-2]m vs 6MWT2: 0 [0-2]; p = 0.007). There were no differences regarding the BP and the SpO2(p>0.05 for all). Although there are statistically significant differences in initial HR between the first and second test, this finding does not seem to be clinically relevant. Therefore, thirty minutes of rest between two 6MWT are sufficient for cardiovascular and symptomatic recovery in patients with COPD.

Simple Lower Limb Functional Tests in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review.

OBJECTIVES: To evaluate the characteristics and available evidence on the measurement properties of the gait speed (GS) test, timed Up and Go test (TUG), sit-to-stand (STS) test, and step test; to investigate their relation with clinical outcomes in chronic obstructive pulmonary disease (COPD); and to provide recommendations for clinical practice and future research. DATA SOURCES: Studies were systematically identified from a literature search using PubMed, PEDro, CINAHL, and Cochrane Library databases and the reference lists of the included articles. STUDY SELECTION: Studies including ≥1 of these 4 lower limb functional tests (GS test, TUG, STS test, and step test) as an outcome in patients with COPD were selected. No limits were applied for language and study design. DATA EXTRACTION: Two researchers independently performed data extraction and, by using the COnsensus-based standards for the Selection of health status measurement INstruments, assessed the quality of those studies that described measurement properties. DATA SYNTHESIS: Forty-two articles met the selection criteria. GS test, STS test, and step test are valid, reproducible, and responsive tests, especially the 4-meter GS, 5-repetition STS test, and 6-minute step test (6MST). The TUG is reliable; however, studies on other measurement properties of this test are lacking. Outcomes of these tests are correlated with mortality, physical activity in daily life, exercise capacity, dyspnea, and quality of life. CONCLUSIONS: Simple and functional lower limb tests provide information about important clinical outcomes in patients with COPD. The 4-meter GS, 5-repetition STS test, and 6MST are tests with well-established psychometric properties, whereas the properties of the TUG need to be studied further.

Perfil dos pacientes com DPOC que melhoram a capacidade de exercício após treinamento / Profile of patients with COPD who improve exercise capacity after training

Introdução: Fatores associados à melhora no incremental shuttle walking test (ISWT), em pacientes com DPOC não estão claros. Objetivo: Identificar o perfil dos pacientes com melhor desempenho no ISWT após treinamento físico. Métodos: Quarenta e dois pacientes com DPOC foram separados em dois grupos: melhora (GM) no ISWT (≥20 metros) e não melhora (GNM). Foram avaliados: espirometria, ISWT, teste da caminhada de seis minutos (TC6min), sensação de dispneia, dados antropométricos e de gravidade da doença. Resultados: Após treinamento, houve melhora na distância do ISWT (P=0,03). O GM apresentou pior desempenho no ISWT (P<0,0001) e maior sensação de dispneia (P=0,04) antes do treinamento. Os integrantes do GM e do GNM não apresentaram diferenças em relação aos dados antropométricos, bem como de gravidade da doença. Conclusões: Pacientes com mais sintomas e pior desempenho no ISWT inicial parecem ser os que mais melhoram sua capacidade máxima de exercício após treinamento físico.

Introduction: Factors associated with improvement in the incremental shuttle walking test (ISWT), in COPD patients, are not clear. Objective: To identify the profile of patients with better performance in the ISWT after physical training. Methods: Forty-two patients with COPD were separated into two groups: improvement (IG) in the ISWT (≥20 meters), and no improvement (NIG). Spirometry, ISWT, six-minute walk test (6MWT), sensations of dyspnea, anthropometric data and disease severity were evaluated. Results: After training, there was an improvement in the ISWT (P = 0.03). Patients from the IG showed poorer performance in the ISWT (P <0.0001) and greater sensation of dyspnea (P = 0.04) before training. Participants in the IG and NIG did not show any differences in anthropometric data and disease severity. Conclusions: Patients with more symptoms and poorer performance on the initial ISWT seem to be the ones who improve more after physical training.

Minimal important difference for anxiety and depression surveys after intervention to increase daily physical activity in smokers / Diferencia mínima importante para cuestionarios a cerca de ansiedad y depresión después de intervención para un aumento de la actividad física diaria en tabaquistas / Diferença mínima importante para questionários de ansiedade e depressão após intervenção para o aumento da atividade física diária em tabagistas

Nicotine dependence is associated with the presence of anxiety and depression. Several instruments (questionnaires) are used to quantify these symptoms; however, it has not been known yet which magnitude of change quantified by these instruments better reflects relevant alterations in these symptoms after an intervention in smokers. The objective of this study was to determine the value of the minimal important difference for questionnaires about anxiety and depression after an intervention aimed at increasing daily physical activity in smokers. Fifty-seven smokers with normal spirometry underwent a program to increase daily physical activity. During the two-month period, they used a pedometer (step counter) and received an informative booklet, both as incentives to increase daily physical activity. Participants were assessed pre- and post-program and, in each assessment, questionnaires that quantify anxiety and depression were applied (Hospital Anxiety and Depression Scale - HADS A and D; State-Trait Anxiety Inventory - STAI, and Beck Depression Inventory - BDI). There was a significant increase in daily physical activity (steps/day) and an improvement in the scores of all questionnaires. Minimal important difference values for this population were eight points for the HADS A, six for HADS D, ten for STAI and 11 for BDI. The present study allowed to determine the minimal important difference values for reduction of anxiety and depression after a support program to increase daily physical activity in smokers. These results indicate a potentially significant change, beyond any measurement error.

La dependencia nicotínica es asociada a la presencia de ansiedad y depresión. Diversos instrumentos (cuestionarios) son usados para cuantificar tales síntomas, pero no se sabe cuál magnitud de mejoría evaluada por medio de ellos reflete cambios relevantes de los síntomas después de una intervención en tabaquistas. El objetivo de eso estudio fue determinar el valor de la diferencia mínima importante para cuestionarios a cerca de ansiedad y depresión después de una intervención que intenta aumentar la actividad física diaria en tabaquistas. Cincuenta y siete tabaquistas con espirometría normal fueron sometidos al programa para aumentar la actividad física diaria. Por un período de dos meses, los participantes utilizaron un podómetro (contador de pasos) y recibieron una cartilla informativa como incentivos para aumentar la actividad física diaria. Los tabaquistas fueron evaluados antes y después del programa y a cada evaluación se aplicaron cuestionarios que cuantifican ansiedad y depresión (Escala Hospitalaria de Ansiedad y Depresión - HADS A y D; Inventario de Ansiedad Tracio-Estadio de Spielberger - STAI y Inventario de Depresión de Beck - BDI). Se observó aumento significante de la actividad física diaria (pasos por día) y mejora de la puntuación de todos los cuestionarios aplicados. Los valores de la diferencia mínima importante para esa populación fueron de ocho puntos para HADS A, seis para HADS D, diez para STAI y 11 para BDI. Con el presente estudio, se puso determinar los valores de la diferencia mínima importante para reducción de ansiedad y depresión después de un programa de incentivo a la actividad física en tabaquistas. Esos resultados indican un cambio potencialmente significativo, además de cualquier error de mensuración.

A dependência nicotínica está associada à presença de ansiedade e depressão. Vários instrumentos (questionários) são utilizados para quantificar tais sintomas; porém, não se sabe qual magnitude de melhora avaliada por meio deles reflete mudanças relevantes destes sintomas após uma intervenção em tabagistas. O objetivo deste estudo foi determinar o valor da diferença mínima importante para questionários de ansiedade e depressão após uma intervenção que visa o aumento da atividade física diária em tabagistas. Cinquenta e sete tabagistas com espirometria normal foram submetidos a um programa para o aumento de atividade física diária. Durante um período de dois meses, os participantes utilizaram um pedômetro (contador de passos) e receberam uma cartilha informativa, ambos como incentivo para aumentar a atividade física diária. Os tabagistas foram avaliados antes e após o programa e, em cada avaliação, aplicaram-se questionários que quantificam ansiedade e depressão (Escala Hospitalar de Ansiedade e Depressão - HADS A e D; Inventário de Ansiedade Traço-Estado de Spielberger - STAI e Inventário de Depressão de Beck - BDI). Houve aumento significativo da atividade física diária (passos/dia) e melhora da pontuação de todos os questionários aplicados. Os valores da diferença mínima importante para esta população foram de oito pontos para HADS A, seis para HADS D, dez para STAI e 11 para BDI. O presente estudo possibilitou determinar os valores da diferença mínima importante para redução da ansiedade e depressão após um programa de incentivo à atividade física em tabagistas. Esses resultados indicam uma mudança potencialmente significativa, além de qualquer erro de medida.

Long-term effects of a program to increase physical activity in smokers.

BACKGROUND: Programs aimed at increasing physical activity in daily life (PADL) have generated growing interest to prevent the deleterious effects of physical inactivity. Recent literature has shown that a short-term protocol using pedometers increased PADL in smokers with normal lung function. However, the long-term effects of such a protocol were not yet studied. The objective of this study was to evaluate the results of 1-year follow-up after a program aimed at increasing PADL in smokers with normal lung function. METHODS: Twenty-four smokers were followed (15 men; mean [interquartile range (IQR)], 51 [41-57] years of age; BMI, 26 [22-29] kg/m2; 20 [20-30] cigarettes/d). Subjects were assessed at baseline, immediately after completion of the program, and 1 year later for PADL, lung function, 6-min walking distance (6MWD), smoking habits, quality of life, anxiety, and depression. The 5-month program used pedometers and informative booklets as interventions. RESULTS: The gains achieved after the program were maintained in the long term: steps/d (postprogram vs 1-year follow-up, mean [IQR]: 10,572 [9,804-12,237] vs 10,438 [9,151-12,862]); 6MWD (625 [530-694] m, 88 [81-97] % predicted vs 609 [539-694] m, 89 [81-96] % predicted), anxiety (34 [26-41] points vs 35 [36-47] points) and depression (6 [2-9] points vs 5 [2-11] points) (P > .05 for all). One year after the program, 20% of the subjects had quit smoking. CONCLUSIONS: In smokers with normal lung function, improvements in daily physical activity, exercise capacity, anxiety, and depression obtained through a 5-month program aimed at increasing physical activity are sustained 1 year after completion of the program. Furthermore, such a program can contribute to smoking cessation in this population.

Reduction of physical activity in daily life and its determinants in smokers without airflow obstruction.

BACKGROUND AND OBJECTIVE: In smokers without airflow obstruction, detailed, objective and controlled quantification of the level of physical inactivity in daily life has never been performed. This study aimed to objectively assess the level of physical activity in daily life in adult smokers without airflow obstruction in comparison with matched non-smokers, and to investigate the determinants for daily physical activity in smokers. METHODS: Sixty smokers (aged 50 (39-54) years) and 50 non-smokers (aged 48 (40-53) years) matched for gender, age, anthropometric characteristics, educational level, employment status and seasons of the year assessment period were cross-sectionally assessed regarding their daily physical activity with a step counter, besides assessment of lung function, functional exercise capacity, quality of life, anxiety, depression, self-reported comorbidities carbon monoxide level, nicotine dependence and smoking habits. RESULTS: When compared with non-smokers, smokers walked less in daily life (7923 ± 3558 vs 9553 ± 3637 steps/day, respectively), presented worse lung function, functional exercise capacity, quality of life, anxiety and depression. Multiple regression analyses identified functional exercise capacity, Borg fatigue, self-reported motivation/physical activity behaviour and cardiac disease as significant determinants of number of steps/day in smokers (partial r(2) = 0.10, 0.12, 0.16 and 0.05; b = 15, -997, 1207 and -2330 steps/day, respectively; overall fit of the model R(2) = 0.38; P < 0.001). CONCLUSIONS: Adult smokers without airflow obstruction presented reduced level of daily physical activity. Functional exercise capacity, extended fatigue sensation, aspects of motivation/physical activity behaviour and self-reported cardiac disease are significant determinants of physical activity in daily life in smokers.

Minimal detectable change of the London chest activity of daily living scale in patients with COPD.

BACKGROUND: Dyspnea and fatigue frequently impair the ability to perform activities of daily living (ADL) in patients with chronic obstructive pulmonary disease. Questionnaires and scales have been used to assess limitations in ADL. The London Chest Activity of Daily Living (LCADL) scale is responsive to intervention to a higher extent when compared with other tools. However, the minimal detectable change (MDC) for this scale remains unknown. The aim of this study was to determine the MDC for functional status improvement measured by the LCADL scale in patients with chronic obstructive pulmonary disease. METHODS: Forty patients (20 men, 66 ± 7 years, forced expired volume in 1 second 44 ± 16% predicted) participated in a 3-month high-intensity exercise training program. Before and after the protocol, participants complete the LCADL scale and the Saint George Respiratory Questionnaire. To calculate the MDC, we used the standard error of measurement and the effect size (distribution-based estimates). RESULTS: There was improvement in the LCADL self-care, domestic and leisure domains, and total score after the training program, with a strong trend for improvement in the physical activity domain. The MDC estimated for the LCADL were 0.89, 2.60, 0.44, 0.58, and 3.88 points for self-care, domestic, physical, and leisure domains, and total score, respectively. Correlations between changes in LCADL and in the Saint George Respiratory Questionnaire were weak (r < 0.4 for all). CONCLUSION: This study provided the MDC for the domains and total score of the LCADL. A change of 4 points in the total score of the LCADL can be interpreted as a meaningful change.

Atividades funcionais e sua relação com a capacidade física em idosos com insuficiência cardíaca / Function activities and their relationship with physical capacity in heart failure

A capacidade de anos adicionais resultantes do aumento na expectativa de vida pode ser comprometida por limitações na performance funcional e estabelcimento de doenças crônicas. A insuficiência cardíaca (IC) resulta em dificuldades na execução de atividades da vida diária (AVDs). Testes de desempenho físico funcional revelam-se instrumentos adicionais para mensurar capacidade de realizar AVDs. Foi objetivo deste estudo avaliar e relacionar atividades funcionais à aptidão física em idosos com IC, além de compara-los a um grupo controle. Quartoze idosos com IC [9 homens/5 mulheres; 67,5 (62-80) anos] e 14 idosos do grupo controle [9 homens/5 mulheres; 67,5(60-77)anos] foram submetidos às seguintes avaliações: capacidade funcional de exercício (teste de caminhada de seis minutos - TC6min); força muscular periférica (teste de uma repetição máxima - IRM) e performance física e funcional (testes de desempenho físico funcional). Idosos com IC apresentaram diminuição da capacidade de exercício, demonstrada por menor distância percorrida no TC6min [46,5 (330-572) versus 551,5(470-728) metros], força muscular periférica de MMSS[5(4-10,5) versus 7,7 (3-12)kg]...

Step counting and energy expenditure estimation in patients with chronic obstructive pulmonary disease and healthy elderly: accuracy of 2 motion sensors.

OBJECTIVE: To compare the accuracy of 2 motion sensors (a pedometer and a multisensor) in terms of step counting and estimation of energy expenditure (EE) in patients with chronic obstructive pulmonary disease (COPD) and in healthy elderly. DESIGN: In this descriptive study, all participants wore both motion sensors while performing a treadmill walking protocol at 3 different speeds corresponding to 30%, 60%, and 100% of the average speed achieved during a six-minute walk test. As criterion methods, EE was estimated by indirect calorimetry, and steps were registered by videotape. SETTING: Research laboratory at a university hospital. PARTICIPANTS: Patients with COPD (n=30; 17 men; mean age +/- SD, 67+/-8 y; mean forced expiratory volume in the first second [FEV(1)] predicted +/- SD, 46%+/-17%; mean body mass index [BMI] +/- SD, 24+/-4 kg.m(2)) and matched healthy elderly (n=30; 15 men; mean age +/- SD, 68+/-7 y; mean FEV(1) predicted +/- SD, 104%+/-21%; mean BMI +/- SD, 25+/-3 kg.m(2)). INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURE: Step counting and EE estimation during a treadmill walking protocol. RESULTS: The pedometer was accurate for step counting and EE estimation in both patients with COPD and healthy elderly at the higher speed. However, it showed significant underestimation at the 2 slower speeds in both groups. The multisensor did not detect steps accurately at any speed, although it accurately estimated EE at all speeds in healthy elderly and at the intermediate and higher speeds in patients with COPD. CONCLUSIONS: In both patients with COPD and healthy elderly, the multisensor showed better EE estimates during most walking speeds than the pedometer. Conversely, for step counting, accuracy is observed only with the pedometer during the higher walking speed in both groups.